Colgate-Palmolive (NYSE:CL) Stock Holdings Lifted by Ballentine Partners LLC

Ballentine Partners LLC lifted its position in Colgate-Palmolive (NYSE:CLFree Report) by 2.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 21,007 shares of the company’s stock after acquiring an additional 460 shares during the period. Ballentine Partners LLC’s holdings in Colgate-Palmolive were worth $1,910,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in CL. XTX Topco Ltd purchased a new position in shares of Colgate-Palmolive in the second quarter worth approximately $423,000. AE Wealth Management LLC increased its position in shares of Colgate-Palmolive by 70.9% in the second quarter. AE Wealth Management LLC now owns 22,607 shares of the company’s stock worth $2,194,000 after acquiring an additional 9,382 shares in the last quarter. Frank Rimerman Advisors LLC increased its position in shares of Colgate-Palmolive by 6,205.3% in the second quarter. Frank Rimerman Advisors LLC now owns 5,927 shares of the company’s stock worth $575,000 after acquiring an additional 5,833 shares in the last quarter. Mount Yale Investment Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the second quarter worth approximately $421,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 79.7% during the second quarter. EverSource Wealth Advisors LLC now owns 3,504 shares of the company’s stock worth $348,000 after purchasing an additional 1,554 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.37% of the stock is currently owned by insiders.

Analyst Ratings Changes

CL has been the subject of several research reports. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. JPMorgan Chase & Co. decreased their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Stifel Nicolaus decreased their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. Finally, TD Cowen decreased their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $101.11.

Read Our Latest Report on CL

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $88.27 on Wednesday. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The firm has a fifty day simple moving average of $92.13 and a 200-day simple moving average of $97.71. The stock has a market capitalization of $72.12 billion, a price-to-earnings ratio of 25.29, a PEG ratio of 3.62 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.